Fennec Pharmaceuticals Inc.
USD10.39
+0.49 (+4.95%)
CEO
Jeffrey S. Hackman
IPO Date
2017-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.17
Prev. Close
$9.90
Day Low
$9.85
Day High
$10.48
52W Low
$5.65
52W High
$11.31
Market Cap
$0.30B
Volume
0.17M
| 15,597 |
| $2.45 |
| 2 Jul 2026 | Raykov Rosty | other: Former Director | S-Sale | Disposed | 9,599 | $10.41 |
| 2 Jul 2026 | Raykov Rosty | other: Former Director | M-Exempt | Disposed | 15,597 | $2.45 |
| 1 Jul 2026 | Evans Terry L | Chief Commercial Officer | A-Award | Acquired | 168 | $0.00 |
| 1 Jul 2026 | Sayad Pierre Sargis | Chief Medical Officer | A-Award | Acquired | 168 | $0.00 |
| 1 Jul 2026 | Hackman Jeffrey S. | director, officer: Chief Executive Officer | A-Award | Acquired | 1,159 | $0.00 |
| 1 Jul 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 1,703 | $0.00 |
| 1 Jul 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A-Award | Acquired | 156 | $0.00 |
| 10 Jun 2026 | Brughera Marco Maria | director | A-Award | Acquired | 20,000 | $8.70 |